Agios Pharmaceuticals, Inc.

AGIO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$76,247$88,205$139,259$203,126
Short-Term Investments$817,463$688,723$643,860$816,892
Receivables$4,109$2,810$2,206$4,378
Inventory$27,616$19,076$8,492$0
Other Curr. Assets$40,165$35,021$38,955$39,835
Total Curr. Assets$965,600$833,835$832,772$1,064,231
Property Plant & Equip (Net)$54,554$69,791$88,116$104,230
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$638,321$29,435$313,874$266,375
Tax Assets$0$0$0$0
Other NC Assets$4,724$4,057$3,956$2,900
Total NC Assets$697,599$103,283$405,946$373,505
Other Assets$0$0$0$0
Total Assets$1,663,199$937,118$1,238,718$1,437,736
Liabilities
Payables$16,643$9,780$18,616$16,700
Short-Term Debt$16,781$15,008$13,663$11,159
Tax Payable$871$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$46,861$43,167$30,350$31,967
Total Curr. Liab.$81,156$67,955$62,629$59,826
LT Debt$40,207$56,988$71,996$85,935
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$880$1,156$3,279$0
Total NC Liab.$41,087$58,144$75,275$85,935
Other Liabilities$0$0$0$0
Cap. Leases$56,988$71,996$85,659$97,094
Total Liabilities$122,243$126,099$137,904$145,761
Equity
Pref Stock$0$0$0$0
Common Stock$73$72$71$71
Retained Earnings-$148,924-$822,649-$470,561-$238,760
AOCI-$1,518-$441-$12,535-$1,198
Other Equity$1,691,325$1,634,037$1,583,839$1,531,862
Total Equity$1,540,956$811,019$1,100,814$1,291,975
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,663,199$937,118$1,238,718$1,437,736
Net Debt-$19,259-$16,209-$53,600-$106,032